Percutaneous treatment of saphenous vein bypass graft obstructions: A continuing obstinate problem

Circulation

Volumn 107, Issue 18, 2003, Pages 2284-2286

  De Feyter, P J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bypass; Editorials; Occlusion; Veins

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ARTIFICIAL EMBOLISM; ATHEROSCLEROSIS; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; COMORBIDITY; EDITORIAL; GRAFT OCCLUSION; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; GRAFT OCCLUSION, VASCULAR; HUMANS; SAPHENOUS VEIN; SYNDROME; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 0038324352     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000069360.38675.22     Document Type: Editorial

References (20)

1. de Feyter PJ, van Suylen RJ, de Jaegere PP, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993:21:1539-1549.
2. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916-931.
3. Mathew V, Clavell AL, Lennon RJ, et al. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med. 2000;108:127-135.
4. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001;38:150-154.
5. Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med. 1997;337:740-747.
6. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659-665.
7. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol. 1994;23:1296-1304.
8. de Jaegere PP, van Domburg RT, Feyter PJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol. 1996;28:89-96.
9. Labinaz M, Sketch MH Jr, Ellis SG, et al. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J. 2001;141:469-477.
10. Kahn JK, Rutherford BD, McConahay DR, et al. Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting. Am J Cardiol. 1990;65:698-702.
11. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. J Am Coll Cardiol. 2000;35:605-611.
12. Al Suwaidi J, Velianou JL, Berger PB, et al. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J. 2001;142:452-459.
13. Rosenschein U, Gaul G, Erbel R, et al. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation 1999;99:26-29.
14. Singh M, Rosenschein, U, Ho KLL, et al. Treatment of saphenous vein bypass graft with ultrasound thrombolysis: a randomized study. Circulation. 2003;107:2331-2336.
15. Kahn JK, Rutherford BD, McConahay DR, et al. Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts. J Am Coll Cardiol. 1994;23:1038-1042.
16. Berger PB, Bell MR, Grill DE, et al. Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. J Am Coll Cardiol. 1996;28:1732-1737.
17. Hartmann JR, McKeever LS, O'Neill WW, et al. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): a serial trial. J Am Coll Cardiol. 1996;27:60-66.
18. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106:3063-3067.
19. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorta-coronary bypass grafts. Circulation. 2002;105:1285-1290.
20. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. Circulation 2002;106(suppl II):1676. Abstract.